Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohns disease who are starting adalimumab.
United States Chapel Hill Jacob Kurowski Michael Kappelman Department Of Pediatric Gastroenterology University Of North Carolina
Source: medscape.com